Centese - Crunchbase Company Profile & Funding

Q: Where is Centese's headquarters?

Centese is located in Omaha, Nebraska, United States.

Q: Who invested in Centese?

Centese has 4 investors including New York Angels And MedTech Venture Partners.

Q: When was the last funding round for Centese?

Centese closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Centese

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Centese

CB Rank

18558

Centese develops cardiothoracic post-operative medical equipment for post-operative surgical care and patient monitoring.

Founded

obfuscation

Private

Venture - Series Unknown

Omaha, Nebraska, United States

11-50

www.centese.com/

Health Care

Medical Device

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Debt Financing

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Evan Luxon: Co-Founder and CEO

Details

Legal Name

Esculon LLC

Also Known As

Esculon

Operating Status

Active

Company Type

For Profit

Founders

Evan Luxon

About the Company

Centese is a medical device company that develops Thoraguard, a reliable surgical drainage system. Using digital intelligence, Thoraguard revolutionizes operative drainage in cardiothoracic surgery. Thoraguard is a digital technology that provides accurate data monitoring and automatic chest tube clearing with the goal of enhancing clinical

judgment and patient safety. Centese is committed to delivering improved post-operative surgical drainage solutions that are designed for safety, intelligence, and effectiveness in order to enhance results and save costs in cardiothoracic surgery.

Phone Number

402-417-0740

Predictions & Insights

Growth Insight

See this Growth Insight

Centese is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Thoraguard

A digital system for cardiothoracic surgery post-operative care, offering automated chest tube clearance and precise data monitoring for air leak rate and drainage volume.

Automated Clog Clearance System

Automatically clears chest tube clogs without manual intervention, enhancing patient safety and monitoring in cardiac surgery.

Research & Development

Centese is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Centese	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Centese	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Centese	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Centese	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Centese	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Centese	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Centese	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Centese	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Centese	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Centese	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
New York Angels	Yes	Venture Round - Centese	Mauri Rosenthal, Tom Hirschfeld
New York Angels	Yes	Venture Round - Centese	Mauri Rosenthal, Tom Hirschfeld
New York Angels	Yes	Venture Round - Centese	Mauri Rosenthal, Tom Hirschfeld
New York Angels	Yes	Venture Round - Centese	Mauri Rosenthal, Tom Hirschfeld
New York Angels	Yes	Venture Round - Centese	Mauri Rosenthal, Tom Hirschfeld